Skip to main content

Bioquest Corp

جودة البيانات: 83%
BQST
OTC Manufacturing Chemicals
KWD 0.51
▲ KWD 0.04 (8.45%)
القيمة السوقية: 15.28 M
السعر
KWD 0.51
القيمة السوقية
15.28 M
نطاق اليوم
KWD 0.51 — KWD 0.51
نطاق 52 أسبوعًا
KWD 0.47 — KWD 1.05
حجم التداول
12
فتح KWD 0.51
متوسط 50 يوم / 200 يوم
KWD 0.50
2.88% above
متوسط 50 يوم / 200 يوم
KWD 0.71
27.57% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -72,781.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.03
Interest Coverage-47.43

التقييم

PE (TTM)
-30.11
أقل من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -30.1 -1.5
P/B 1.6
ROE % -53.4
Net Margin % -41.5
Rev Growth 5Y % 1.8
D/E 0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -507,406.0
ROE N/A ROA -6733.54%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -72,781.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.03
Interest Coverage -47.43 Asset Turnover N/A
Working Capital -536,419 Tangible Book Value -536,419
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -30.11 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.48%
Market Cap 15.28 M Enterprise Value 15.26 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 14.34%
SBC-Adj. FCF -222,781 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2014
Revenue 0.0
Net Income -821,022.0 -2.32 M -616,186.0
EPS (Diluted)
Gross Profit
Operating Income -817,920.0 -2.20 M -251,903.0
EBITDA
R&D Expenses
SG&A Expenses
D&A
Interest Expense 30,000.0 37,638.0
Income Tax 0.0

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2014
Total Assets 33,540.0 17,097.0 889,903.0
Total Liabilities 466,530.0 1.79 M 14,700.0
Shareholders' Equity -432,990.0 -1.77 M 875,203.0
Total Debt
Cash & Equivalents 33,540.0 260.0 543,853.0
Current Assets 33,540.0 17,097.0 889,903.0
Current Liabilities 466,530.0 1.79 M 14,700.0